Ming Yu
Professor
Department of Nutrition and Food Hygiene, School of Public Health
Tianjin Medical University
22 Qixiangtai Road
Tianjin 300070
Phone: +86-22-83336610
Email Address: minnieyu@tmu.edu.cn
Education
Ph.D., Oncology, Tianjin Medical University, Tianjin, China, 2002
M.S., Nutrition and Food Hygiene, Tianjin Medical University, Tianjin, China, 1999
B.S., Nutrition and Food Hygiene, Tianjin Medical University, Tianjin, China, 1996
Professional Background
2009- Professor, Tianjin Medical University, Department of Nutrition and Food Hygiene, School of Public Health
2004-2009 Associate Professor, Tianjin Medical University, Department of Nutrition and Food Hygiene, School of Public Health
2001-2004 Lecturer, Tianjin Medical University, Department of Nutrition and Food Hygiene, School of Public Health
1996-2001 Assistant, Tianjin Medical University, Department of Nutrition and Food Hygiene, School of Public Health
Other Roles
1.Member of Tianjin Food Association
Publications
1.Overall Structural Alteration of Gut Microbiota and Relationships with Risk Factors in Patients with Metabolic Syndrome Treated with Inulin Alone and with Other Agents: An Open-Label Pilot Study. Mediators Inflamm, 2022 May 19; 2022:2078520. doi: 10.1155/2022/2078520.
2.Research of influencing factors and their interaction effects on hyperuricemia in physical examination subjects. Journal of Community Medicine, 2021, 19(13): 788-791.
3.Proteasome inhibitor MG132 suppresses pancreatic ductal adenocarcinoma-cell migration by increasing ESE3 expression. Oncol Lett, 2020, 19(1):858-868.
4.Increased dietary fatty acids determine the fatty-acid profiles of human pancreatic cancer cells and their carrier's plasma, pancreas and liver. Endocr J, 2020, 67(4):387-395.
5.Correlation of BMI and hemoglobin level during first trimester with gestational blood glucose level. Chinese Journal of Prevention and Control of Chronic Diseases, 2019, 27(12): 881-884.
6.The invasion ability of PDAC was increased by down-regulating ESE3 expression under the conditions of hypoxia and glucose deprived. Tianjin Medical Journal, 2019, 47(3): 225-229.
7.Soft drinks consumption is associated with nonalcoholic fatty liver disease independent of metabolic syndrome in Chinese population. Eur J Nutr, 2018, 57(6): 2113-2121.
Grants
1.National Natural Science Foundation of China. Proteomic study on the improvement of sarcopenia in elderly patients by inhibiting muscle stem cell function decline based on vitamin D (82373562). 2024.01-2027.12.
2.National Natural Science Foundation of China. Mechanism study of tumor associated fibroblasts in proliferation and metastasis of pancreatic ductal adenocarcinoma (82173295). 2022.01-2025.12.
3.Ministry of Science and Technology Foundation. Proactive health and coping stategies for aging (2020YFC2006300). 2020.01-2023.12.
4.Tianjin Municipal Science and Technology Planning Project. Study on metabolic syndrome components combined with gut microbiota and metabonomics in early screening and intervention of diabetes (17ZXMFSY00030). 2017.10-2020.09.
5.Tianjin Municipal Science and Technology Planning Project. Study on the risk assessment model and the preventive effect of blackraspberry in pancreatic cancer (17ZXMFSY00010). 2017.10-2021.12.
6.National Natural Science Foundation of China. Study on the expression and regulation mechanism of Foxp3 in pancreatic cancer cells under hypoxia microenvironment (81272685). 2013.01-2016.12.
7.Natural Science Key Project of Tianjin. Mechanism of leptin regulating hTERT expression in inhibiting the proliferation of pancreatic cancer cells (11JCZDJC18400). 2011.04-2014.12.
8.National Natural Science Foundation of China. Regulation of NF-κB/hTERT signal network in doxorubicin resistance in breast cancer (30701013). 2008.01-2010.12.
9.Tianjin High Education Science and Technology Development Fund. The effects of mitochondrial pathway in the apoptosis of breast cancer cells induced by soybean isoflavone and TRAIL (20060210). 2006.10-2009.09.
10.Natural Science Foundation of Tianjin. Molecular epidemiological study on acroral neuromicrovascular lesions in diabetes (023611911). 2002.04-2005.03.